Clinical Trial Update: Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pomalidomide, ixazomib, and dexamethasone in patients with previously treated multiple myeloma or plasma cell leukemia completed, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasma Cell Leukemia
• Plasma Cell Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Ixazomib citrate (Ixazomib)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Plasma Cell Leukemia, Plasma Cell Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2022-05-23